• Thu news: Industry M&A volume down 8% over 2023. Pfizer’s Ibrance improves breast cancer survival. Lonza shedding capsule biz. AZ’s Lynparza in early breast cancer. Trump wants childhood vaccine discussion. See more on our front page

Organizational restructuring and new focus for growth







Heard company is going through complete managerial re-org. and effort to focus on new growth. Is anyone seeing a shift to a more sales-oriented culture?
Nope. The new managerial team fell on their face and still can't get up. JA and SZ were fired and NS is in hiding. A bunch of good reps found better jobs and now CBL does not have a salesforce. Unfortunately CBL can't find anyone to work for them. CBL is good at Pathology but terrible at business.